A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/47 (2006.01) A61K 31/195 (2006.01) A61K 31/401 (2006.01) A61K 31/495 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2462875
Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula (I) where R1, R2, R3, B, Jl, J2, X and Z are as defined herein.
L'invention concerne des méthodes permettant de traiter la maladie d'Alzheimer et d'autres maladies, et/ou d'inhiber l'enzyme bêta-sécrétase, et/ou d'inhiber le dépôt de peptide bêta A chez un mammifère, par l'utilisation de composés de formule (I), dans laquelle R¿1?, R¿2?, R¿3?, B, J?1¿, J?2¿, X et Z sont tels que définis dans la description.
Elan Pharmaceuticals Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
Allylamides useful in the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allylamides useful in the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allylamides useful in the treatment of alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1523760